K254168 - Actolind® (06.3637. Actolind® Gel Plus)

K254168 is an FDA 510(k) clearance for the Actolind® (06.3637. Actolind® Gel Plus). Classified as Dressing, Wound, Drug (product code FRO).

Submitted by ACTO GmbH (Braunschweig, DE). The FDA issued a Cleared decision on September 22, 2026 after a review of 273 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all ACTO GmbH devices